FNY Managed Accounts LLC - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
FNY Managed Accounts LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2018$0–50
+100.0%
0.00%–
Q4 2017$0–25
-75.0%
0.00%–
Q3 2017$0
-100.0%
100
-37.9%
0.00%
-100.0%
Q2 2015$1,610,000
-99.4%
161
-99.6%
0.00%
-99.0%
Q1 2015$253,160,000–42,100–0.21%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q4 2017.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders